Related content

A HLA-DQ5 restricted Melan-A/MART-1 epitope presented by melanoma tumor cells to CD4+ T lymphocytes

By Larrieu Pierre   Ouisse Laure-Hélène   Guilloux Yannick   Jotereau Francine   Fonteneau Jean-François  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 10, 2007-10 ,pp. : 1565-1575

Springer Publishing Company

Access to resources Recommend Favorite

Long-term follow-up of patients treated by adoptive transfer of melanoma tumor-infiltrating lymphocytes as adjuvant therapy for stage III melanoma

By Khammari Amir   Nguyen Jean-Michel   Pandolfino Marie   Quereux Gaëlle   Brocard Anabelle   Bercegeay Sylvain   Cassidanius Alain   Lemarre Philippe   Volteau Christelle   Labarrière Nathalie   Jotereau Francine   Dréno Brigitte  

Cancer Immunology, Immunotherapy, Vol. 56, Iss. 11, 2007-11 ,pp. : 1853-1860

Springer Publishing Company

Access to resources Recommend Favorite

Tumor-Infiltrating Lymphocytes Predict Response to Neoadjuvant Chemotherapy in Patients with Breast Carcinoma

By Hornychova Helena   Melichar Bohuslav   Tomsova Marketa   Mergancova Jindøiska   Urminska Hana   Ryska Ales  

Cancer Investigation, Vol. 26, Iss. 10, 2008-12 ,pp. : 1024-1031

Informa Healthcare

Access to resources Recommend Favorite

Tumor-Infiltrating Lymphocytes Contain Higher Numbers of Type 1 Cytokine Expressors and DR+ T Cells Compared with Lymphocytes from Tumor Draining Lymph Nodes and Peripheral Blood in Patients with Cancer of the Uterine Cervix

By Santin A.D.   Ravaggi A.   Bellone S.   Pecorelli S.   Cannon M.   Parham G.P.   Hermonat P.L.  

Gynecologic Oncology, Vol. 81, Iss. 3, 2001-06 ,pp. : 424-432

Elsevier

Access to resources Recommend Favorite

Adoptive cell therapy with autologous tumor-infiltrating lymphocytes and high-dose interleukin-2 for metastatic melanoma: The surgeon's perspective

By                    

Experimental and Therapeutic Medicine, Vol. 3, Iss. 5, 2012-01 ,pp. : 898-902

Spandidos Publications

Access to resources Recommend Favorite